Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants
What is a stroke, and what causes it?
A stroke happens when blood flow to part of the brain stops and brain cells begin to die within minutes. About 87 percent are ischemic strokes, caused by a clot, often from narrowed arteries or from the heart in people with atrial fibrillation. The rest are hemorrhagic, caused by a burst blood vessel bleeding into the brain. A transient ischemic attack, or mini stroke, is a blockage that clears on its own; it causes no lasting damage but is a strong warning that a full stroke may follow. The biggest risk factor is high blood pressure, followed by smoking, diabetes, high cholesterol, atrial fibrillation, and physical inactivity. Stress alone does not cause a stroke, but it raises blood pressure and pushes the habits that do.
Symptoms come on suddenly: a drooping face, a weak arm or leg on one side, slurred or confused speech, sudden vision loss, dizziness, or a severe headache with no cause. The FAST rule, face, arms, speech, time, exists because treatment is time dependent. Clot dissolving medicine must be given within 4.5 hours of the last time a person was known to be well, and mechanical clot removal, in which a catheter pulls the clot out of a large artery, can help selected people up to 24 hours. Many strokes are silent, found later on scans, and still raise the risk of a major one. After the emergency, recovery depends on rehabilitation, and the brain's ability to rewire is now the target of trials using electrical and magnetic stimulation, home based devices, and new medicines.
Types of stroke clinical trials
Acute treatment trials. New clot dissolving medicines, clot removal devices and techniques, and treatments given alongside thrombectomy to protect brain tissue. These enroll people in the emergency setting, often through consent from a family member.
Recovery and rehabilitation trials. Brain stimulation paired with physical therapy, home based electrical stimulation, speech therapy for aphasia, and vision rehabilitation, in people months or years after a stroke.
Prevention trials. Blood pressure, cholesterol, and anticoagulant strategies after a first stroke or mini stroke, and new blood thinners that may carry less bleeding risk.
Imaging and prognosis studies. Research on which scans and blood markers predict recovery, so therapy can be targeted.
Hemorrhagic stroke trials. Blood pressure control, surgery techniques, and treatments to limit damage after brain bleeding.
Post stroke conditions. Studies of fatigue, depression, and cognitive change after stroke, which affect most survivors.
Stroke risk is driven by high blood pressure, atrial fibrillation, and type 2 diabetes, each with its own trials. Recovery studies increasingly run at home; see our remote clinical trials page.
Who can participate in stroke clinical trials?
It depends entirely on timing. Acute trials enroll people within hours of symptom onset, usually at the hospital where they arrive; you cannot apply in advance, but knowing which hospitals participate matters. Recovery trials are where most people apply themselves: they enroll adults, often 18 to 80 or 85, who had a stroke months to years ago and have a specific remaining problem, such as arm weakness, trouble speaking, or a vision deficit. Many require that you can follow instructions and attend sessions several times a week, and brain stimulation studies exclude people with seizures or metal implants. Prevention trials enroll people after a stroke or mini stroke, often with a particular risk factor. Eligibility always varies by study.
The phases after a stroke, and why they matter for trials
Hyperacute (first 24 hours). Clot busting and clot removal. Trials run in emergency departments and stroke centers.
Acute (first days to weeks). Preventing complications and a second stroke, starting rehabilitation. Trials of early mobilization and medicines to protect the brain.
Subacute (weeks to about six months). The window of greatest natural recovery. Many rehabilitation trials enroll here.
Chronic (beyond six months). Recovery slows but does not stop. Brain stimulation, home device, and aphasia trials often enroll people years out, which surprises many survivors told that recovery had plateaued.
Study titles say "acute," "subacute," or "chronic stroke" and name the deficit. The date of your stroke and your main remaining difficulty tell you which studies fit.
How can you prevent a stroke?
By controlling the risk factors that cause most of them: keeping blood pressure in range, not smoking, managing diabetes and cholesterol, treating atrial fibrillation with blood thinners when prescribed, staying active, and limiting alcohol. Prevention trials test better ways to do each of these after a first stroke or mini stroke.
Do stroke trial participants get paid?
Some studies offer compensation for time and travel, and study related care, including therapy sessions and devices that are part of the study, is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
How to enroll in a stroke clinical trial
Identify your trial. Use the filters. Titles say "acute" or "chronic stroke" and name the problem being treated, such as "aphasia" or "upper limb."
Select your preferred location. Enter your city or state. Rehabilitation trials often need visits several times a week, so distance matters; some run partly at home.
Explore study details. Click "Learn More" for how long since the stroke is required, the type of deficit, and session frequency.
Complete the health profile. Click "Get started" to begin the 5-step application. Have three things ready: the date and type of your stroke, your main remaining difficulties, and your current medicines, especially blood thinners. A family member can complete the application on your behalf.
Submit the application. A clinical trial coordinator reviews it and contacts you. Nothing is decided until informed consent, and participation is voluntary at every step.